What Happens in Vegas: PEP to PrEP Opportunities

Exposure to Human Immunodeficiency Virus (Event) Clinical Trial

Official title:

What Happens in Vegas: Identifying Opportunities to Expand an HIV Prevention Network to Improve PEP and PrEP Delivery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03775083
• Other study ID #: HFC018001
• Status: Recruiting
• Start date: September 1, 2018
• Est. completion date: August 31, 2019

Study information

• Verified date: December 2018
• Source: Huntridge Family Clinic
• Contact: John (Rob) Phoenix, MSN, APRN
• Phone: 702-979-1111
• Email: jphoenixaprn[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Observational study looking at barriers to care for individuals seeking care, Post Exposure Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP) and surveyed about barriers to care or perceptions of care

Description:

The primary objective of this study is to assess the rate of engagement in a PEP to PrEP HIV provider network for those patients presenting following a non-occupational HIV exposure.

The development of a referral network and intensive clinical follow up of PEP patients will result in more patients appropriately initiating PEP, being referred to appropriate follow up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the PEP medications.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 75
• Est. completion date: August 31, 2019
• Est. primary completion date: August 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Actual or perceived non-occupational exposure to HIV, by self report, within 72 hours of enrollment and referred for care

• able and willing to provide informed consent

• available for 12 months of post expoure follow-up Southern Nevada Ryan White defined service area

Exclusion Criteria:

• HIV+ at time of screeing via 4th genderation (Antibody/Antigen) testing

• Current PEP and/or PrEP product condrainidications as listed in the medication product insert.

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• Exposure to Human Immunodeficiency Virus (Event)
• HIV Infections
• Immunologic Deficiency Syndromes

Intervention

Drug:
• Currently approved medications
subjects will be treated according to current Department of Health and Human Services (DHHS) Center for Disease control and prevention (CDC), Society for Healthcare Epidemiology of American (SHEA guidelines for nPEP

Locations

Country	Name	City	State
United States	Huntridge Family Clinic	Las Vegas	Nevada

Sponsors (1)

Lead Sponsor	Collaborator
Huntridge Family Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	rate of engagement	Assess the rate of engagement in a PEP to PrEP HIV prevention provider network for those patients presenting following a non-occupational HIV exposure	from enrollment to day 90
Secondary	characteristics	Describe the characteristics of patients successfully engaging in HIV prevention via a patient collected survey using a qualtric survey.	from enrollment through end of study for all participants
Secondary	barriers	Identify and assess barriers to access to HIV prevention care including PEP in the period immediately following HIV exposure from a patient collected survey using a qualtric survey tool	from enrollment through end of study for all participants
Secondary	Network characteristics	Analyze the network characteristics that faciliate engagement in HIV prevention services from a patient collected survey using a qualtric survey tool	from enrollment through end of study for all participants
Secondary	transition barriers	Determine and assess to transitioning from PEP to PrEP from a patient collected survey using a qualtric survey tool	from enrollment through end of study for all participants
Secondary	Retention	Compare and contrast the barriers to access and ongoing retention to PrEP from a patient collected survey using a qualtric survey tool.	from enrollment through end of study for all participants